Skip to main content

Table 1 Study cohort characteristics

From: Prominent epigenetic and transcriptomic changes in CD4+ and CD8+ T cells during and after pregnancy in women with multiple sclerosis and controls

 

MS (n = 11)

HC (n = 7)

Samples

  

Pre-pregnancy, n

6

N/A

1st trimester, n; gw median (range)

11; 10.0 (8.0–13.0)

7; 11.9 (10.7–12.0)

2nd trimester, n; gw median (range)

11; 25.0 (23.1–26.3)

7; 25.0 (24.6–26.3)

3rd trimester, n; gw median (range)

11; 35.0 (33.0–36.1)

7; 35.0 (33.7–35.3)

Post-partum, n; week median (range)

11; 6.0 (3.7–7.0)

7; 6.9 (4.3–12.9)

Subject characteristics

  

Age (years), mean ± SD

31.8 ± 2.1

27.7 ± 3.4

BMI, mean ± SD

23.9 ± 3.8

22.7 ± 3.1

Current pregnancy

  

Gw at delivery, mean ± SD

40.1 ± 0.9

39.3 ± 1.2

Fetal sex

5 males/ 6 females

3 males/ 4 females

Mode of delivery

  

Vaginal delivery, n

10

7

Cesarean section, n

1

0

Pregnancy history (mean ± SD)

  

Parity

0.6 ± 0.8

0.4 ± 0.8

Previous miscarriages

0.3 ± 0.9

0.1 ± 0.4

Previous live births

0.6 ± 0.8

0.4 ± 0.8

Disease parameters

  

Disease duration, mean ± SD

7.4 ± 6.2

N/A

Disease severity

  

EDSS at inclusion, median (range)

0.5 (0–2.5)*

N/A

EDSS post-partum, median (range)

0.5 (0–2.0) + 

N/A

Treatment

  

Treatment washout (weeks)

  

From pre-P sampling, median (range)

8.0 (0–20.9)

N/A

From 1st trimester sampling, median (range)

14.9 (2.0–48.3)

N/A

  1. BMI body mass index kg/m2, EDSS Expanded Disability Status Score, gw gestational week, HC healthy controls, MS multiple sclerosis, SD standard deviation
  2. *Data on EDSS were missing for 1 individual, + data on EDSS were missing for 5 individuals